Loading...
XJPX
4671
Market cap164mUSD
Jul 10, Last price  
2,682.00JPY
1D
0.75%
1Q
2.37%
Jan 2017
82.32%
Name

Falco Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:4671 chart
P/E
13.32
P/S
0.62
EPS
201.39
Div Yield, %
4.71%
Shrs. gr., 5y
-0.70%
Rev. gr., 5y
-0.01%
Revenues
43.58b
+0.61%
37,461,000,00037,461,000,000057,027,000,00060,828,000,00062,758,000,00058,401,000,00046,593,000,00048,727,000,00045,971,000,00045,962,000,00044,156,000,00043,185,000,00043,608,000,00050,007,000,00046,913,000,00043,007,000,00043,313,000,00043,578,000,000
Net income
2.02b
+5.00%
115,000,000115,000,0000950,000,000683,000,0001,290,000,0002,278,000,0001,117,000,0001,347,000,0001,478,000,0001,697,000,000653,000,0001,243,000,0001,853,000,0003,533,000,0002,261,000,0001,666,000,0001,920,000,0002,016,000,000
CFO
2.88b
+9.89%
2,294,000,0002,294,000,0003,292,000,0002,362,000,0004,124,000,0005,431,000,000375,000,0001,054,000,0002,009,000,0001,220,000,0002,321,000,0001,651,000,0001,901,000,0002,937,000,0004,129,000,0002,086,000,0003,433,000,0002,619,000,0002,878,000,000
Dividend
Sep 29, 202664 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institutions and various corporations throughout Japan. Its comprehensive range of clinical testing encompasses specialized areas such as genetics, biochemistry, hematology, pathology, immunology, microbiology, and radioimmunoassay. Beyond direct diagnostics, FALCO HOLDINGS also engages in genomic-based drug discovery and the development of biotechnological pharmaceuticals. The company's offerings extend to medical information technology services, as well as environmental and food sanitation testing. They also provide genetic testing tailored for the food industry, catering to manufacturers, retailers, and restaurants. Additionally, FALCO HOLDINGS operates dispensing pharmacies and drugstores. They are also active in the development and sale of medical information systems, notably including "@home Dr.," an electronic medical record system designed for clinics with a high volume of clinical testing, and "TASCAL for ASP," a robust medical support system.
IPO date
Apr 01, 1997
Employees
1,159
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT